Uncategorized - September 3, 2020
AlgoDx receives regulatory approval for sepsis prediction study
AlgoDx, which focuses on supporting disease prediction with machine learning algorithms, has announced the obtention of regulatory approval from the Swedish Medical Products Agency (MPA) to start a sepsis prediction study at an Intensive Care Unit (ICU) in Sweden. The study has previously been approved by the National Ethics Committee through an expedited review for […]
Financing - August 20, 2020
Pilloxa receives 580k EUR from EU
The company has received 580k EUR in funding from the EU’s EUROSTARS program. Pilloxa is developing digital patient-centric solutions and will, together with the University of Oslo, now validate an innovation that supports the patient to take their medication as prescribed and further develop the solution to increase the quality and effectiveness of drug treatment […]
Business article - July 24, 2020
Interview: Using AI to improve early diagnosis
Finnish Combinostics is aiming to expand its platform for early detection of neurodegeneration into new markets and sees an increasing demand for technologies such as theirs. Combinostics was founded in Tampere in 2014 and its technology is built on research at the VTT Technical Research Centre of Finland, studying AI and machine learning for diagnostics. […]
MedTech Award - May 25, 2020
BC Platforms wins Health Innovation Award
BC Platforms and Kaiser Permanente have announced they are winners of the 2020 Microsoft Health Innovation Award in the Reimagine Health Category for enabling a unique way of pairing clinical and genomic data on the same platform to advance precision medicine capabilities. BC Platforms and Kaiser Permanente collaborated using Microsoft’s Azure cloud platform to safely […]
Pharma Business - May 12, 2020
Orexo acquires US rights to commercialize deprexis
Orexo has acquired the exclusive US rights to GAIA AG´s (GAIA) deprexis, a digital therapy to help patients manage their symptoms of depression. The announcement follows two earlier agreements with GAIA where Orexo acquired the exclusive US commercial rights to vorvida which has been proven to reduce risky drinking patterns in adults with alcohol use […]
Financing - February 27, 2020
AlgoDx raises 6 million SEK
AlgoDx, which focuses on supporting disease detection and prediction with machine learning algorithms, has closed a 6 million SEK seed round led by Nascent Invest with participation from angel investors Fredrik Sjödin and Tomas Mora-Morrison, co-founder of Cambio Healthcare Systems. AlgoDx’s first product, ExPRESS, has been developed to autonomously predict sepsis in hospitalized patients using […]
